Big pharma will benefit from new ADME LIMS

A ‘Top 10’ pharmaceutical company is one of the first to implement Debra 5.7.7, the latest release of LabLogic Systems’ LIMS for drug metabolism studies. Recent developments in the software, in particular the new Protein Binding and Pooling modules, will bring efficiency improvements to the company’s research centres in Switzerland and the USA, which have been using Debra 5.4 since 2002.

Please to read the entire article.

You must be logged in to post a comment Login